KCG
ALXA

Knight Capital Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Knight Capital Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$265K Buy
+61,466
New +$279K ﹤0.01% 2396

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return

Knight Capital Group's ALXA Position: Q2 2013 in Review

Knight Capital Group opened a new position in Alexza Pharmaceuticals Inc (ALXA) in Q2 2013: 61,466 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #2396 among its holdings.

30 funds tracked by Wall St. Rank hold ALXA as of Q2 2013.

  • Knight Capital Group held 61,466 shares of Alexza Pharmaceuticals Inc worth $265K as of Q2 2013.
  • Alexza Pharmaceuticals Inc was a new Knight Capital Group position in Q2 2013.
  • Alexza Pharmaceuticals Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2396 holding.
  • 30 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.